Selskabets formål er at være klasse A kommanditist i Nordic Biotech K/S.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -242 t. | 2.1 mio. | 3.6 mio. | 3.5 mio. | - | |
CVR: 26284384
Companies in the same industry and area
CVR 10370671
CVR 31065372
CVR 33596200
CVR 37033553
CVR 27130860
Company entered liquidation
Jakob Mosegaard Larsen joined as liquidator
Florian Schønharting left as director
Company entered liquidation